Journals / Anadolu Kardiyoloji Dergisi / 2013 / Cilt: 13 - Sayı: 4

Life-long oral anticoagulant therapy and rupture of corpus luteum

Yaşam boyu oral antikoagülan tedavisi ve korpus luteum rüptürü

Pages
407–408
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

AKMAN, L., YENİEL, A. Ö., ERGENOĞLU, A. M., AKDEMİR, A. (2022). Life-long oral anticoagulant therapy and rupture of corpus luteum. Anadolu Kardiyoloji Dergisi, Cilt: 13 - Sayı: 4, 407–408. https://ajindex.com/articles/436273

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Cannegieter SC, Rosendaal FR, Brieèt E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635-41. [CrossRef] 2. Payne JH, Maclean RM, Hampton KK, Baxter AJ, Makris M. Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill. Haemophilia 2007;13:93–7. [CrossRef] 3. Bogers JW, Huikeshoven FJ, Lotgering FK. Complications of anticoagulant therapy in ovulatory women. Lancet 1991; 337: 618-9. [CrossRef] 4. Sönmezer M, Atabekoğlu C, Cengiz B, Dökmeci F, Cengiz SD. Depot- medroxygesterone acerate in anticoagulated patients with previous hemorrhagic corpus luteum Eur J Contracept Reprod Health Care 2005; 10: 9-14. [CrossRef] 5. Culwell KR, Curtis KM. Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review. Contraception 2009; 80: 337-45. [CrossRef]